Daniel Asher
CIK: 0001251859
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (20 total)
- Feb 19, 2026EKSO
EKSO BIONICS HOLDINGS, INC.
Purchase(P)Indirect15.5K shares at avg. $12.30$191K - Feb 19, 2026EKSO
EKSO BIONICS HOLDINGS, INC.
Purchase(P)Indirect1.2K shares at avg. $9.60$12K - Feb 13, 2026EKSO
EKSO BIONICS HOLDINGS, INC.
Purchase(P)Indirect16.1K shares at avg. $8.96$144K - Feb 13, 2026EKSO
EKSO BIONICS HOLDINGS, INC.
Purchase(P)Indirect11.1K shares at avg. $9.14$101K - Feb 12, 2026EKSO
EKSO BIONICS HOLDINGS, INC.
Purchase(P)Indirect8.9K shares at avg. $9.18$82K - Feb 12, 2026EKSO
EKSO BIONICS HOLDINGS, INC.
Purchase(P)Indirect30.1K shares at avg. $9.69$292K - Feb 11, 2026EKSO
EKSO BIONICS HOLDINGS, INC.
Purchase(P)Indirect20.6K shares at avg. $9.69$200K - Feb 10, 2026EKSO
EKSO BIONICS HOLDINGS, INC.
Purchase(P)Indirect10.2K shares at avg. $9.92$101K - Feb 9, 2026EKSO
EKSO BIONICS HOLDINGS, INC.
Purchase(P)Indirect4.8K shares at avg. $9.96$48K - Feb 6, 2026EKSO
EKSO BIONICS HOLDINGS, INC.
Purchase(P)Indirect194 shares at avg. $9.86$2K - Jan 26, 2026SQNS
SEQUANS COMMUNICATIONS
Purchase(P)Indirect12.3K shares at avg. $5.12$63K - Jan 21, 2026SQNS
SEQUANS COMMUNICATIONS
Purchase(P)Indirect22.6K shares at avg. $5.24$118K - Jan 20, 2026SQNS
SEQUANS COMMUNICATIONS
Purchase(P)Indirect19.7K shares at avg. $5.29$104K - Jan 16, 2026SQNS
SEQUANS COMMUNICATIONS
Purchase(P)Indirect11.6K shares at avg. $5.65$66K - Jan 15, 2026SQNS
SEQUANS COMMUNICATIONS
Purchase(P)Indirect28.2K shares at avg. $5.65$159K - Jan 14, 2026SQNS
SEQUANS COMMUNICATIONS
Purchase(P)Indirect15.1K shares at avg. $5.69$86K - Jan 13, 2026SQNS
SEQUANS COMMUNICATIONS
Purchase(P)Indirect57.8K shares at avg. $5.51$319K - Jan 12, 2026sqns
SEQUANS COMMUNICATIONS
Purchase(P)Indirect6.8K shares at avg. $5.36$36K - Jan 9, 2026sqns
SEQUANS COMMUNICATIONS
Purchase(P)Indirect27K shares at avg. $5.00$135K - Jan 7, 2026SQNS
SEQUANS COMMUNICATIONS
Purchase(P)Indirect21.9K shares at avg. $4.91$108K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 19, 2026 |  EKSO EKSO BIONICS HOLDINGS, INC. | Purchase(P) | 15,540 | $12.30 | $191,162 | Indirect |
| Feb 19, 2026 | EKSO EKSO BIONICS HOLDINGS, INC. | Purchase(P) | 1,200 | $9.60 | $11,520 | Indirect |
| Feb 13, 2026 | EKSO EKSO BIONICS HOLDINGS, INC. | Purchase(P) | 16,100 | $8.96 | $144,274 | Indirect |
| Feb 13, 2026 | EKSO EKSO BIONICS HOLDINGS, INC. | Purchase(P) | 11,092 | $9.14 | $101,413 | Indirect |
| Feb 12, 2026 | EKSO EKSO BIONICS HOLDINGS, INC. | Purchase(P) | 8,908 | $9.18 | $81,815 | Indirect |
| Feb 12, 2026 | EKSO EKSO BIONICS HOLDINGS, INC. | Purchase(P) | 30,124 | $9.69 | $291,841 | Indirect |
| Feb 11, 2026 | EKSO EKSO BIONICS HOLDINGS, INC. | Purchase(P) | 20,611 | $9.69 | $199,770 | Indirect |
| Feb 10, 2026 | EKSO EKSO BIONICS HOLDINGS, INC. | Purchase(P) | 10,200 | $9.92 | $101,225 | Indirect |
| Feb 9, 2026 | EKSO EKSO BIONICS HOLDINGS, INC. | Purchase(P) | 4,800 | $9.96 | $47,820 | Indirect |
| Feb 6, 2026 | EKSO EKSO BIONICS HOLDINGS, INC. | Purchase(P) | 194 | $9.86 | $1,912 | Indirect |
| Jan 26, 2026 |  SQNS SEQUANS COMMUNICATIONS | Purchase(P) | 12,300 | $5.12 | $62,974 | Indirect |
| Jan 21, 2026 | SQNS SEQUANS COMMUNICATIONS | Purchase(P) | 22,600 | $5.24 | $118,431 | Indirect |
| Jan 20, 2026 | SQNS SEQUANS COMMUNICATIONS | Purchase(P) | 19,660 | $5.29 | $104,082 | Indirect |
| Jan 16, 2026 | SQNS SEQUANS COMMUNICATIONS | Purchase(P) | 11,631 | $5.65 | $65,740 | Indirect |
| Jan 15, 2026 | SQNS SEQUANS COMMUNICATIONS | Purchase(P) | 28,200 | $5.65 | $159,434 | Indirect |
| Jan 14, 2026 | SQNS SEQUANS COMMUNICATIONS | Purchase(P) | 15,100 | $5.69 | $85,853 | Indirect |
| Jan 13, 2026 | SQNS SEQUANS COMMUNICATIONS | Purchase(P) | 57,809 | $5.51 | $318,510 | Indirect |
| Jan 12, 2026 |  sqns SEQUANS COMMUNICATIONS | Purchase(P) | 6,800 | $5.36 | $36,419 | Indirect |
| Jan 9, 2026 | sqns SEQUANS COMMUNICATIONS | Purchase(P) | 27,032 | $5.00 | $135,092 | Indirect |
| Jan 7, 2026 | SQNS SEQUANS COMMUNICATIONS | Purchase(P) | 21,900 | $4.91 | $107,514 | Indirect |
1-20 of 20 transactions
About ASHER DANIEL
ASHER DANIEL (SEC CIK 0001251859) files insider reports with the SEC as 10% Owner of EKSO BIONICS HOLDINGS, INC. (EKSO) and 10% Owner of SEQUANS COMMUNICATIONS (SQNS).
Signal8 holds 12 ownership filings by ASHER DANIEL (3 Form 3, 9 Form 4), filed between Jan 9, 2026 and Feb 20, 2026. Those filings report 20 transactions, from Jan 7, 2026 to Feb 19, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on ASHER DANIEL's filings is in OAK PARK, IL.
Recent filings by ASHER DANIEL
- Feb 19, 2026: Open-market purchases of EKSO shares (2 lines, Form 4, code P).
- Feb 13, 2026: Open-market purchases of EKSO shares (2 lines, Form 4, code P).
- Feb 12, 2026: Open-market purchases of EKSO shares (2 lines, Form 4, code P).
- Feb 11, 2026: Open-market purchase of EKSO shares (Form 4, code P).
- Feb 10, 2026: Open-market purchase of EKSO shares (Form 4, code P).
Other insiders filing for EKSO BIONICS HOLDINGS, INC. (EKSO)
- Jones Jason C, Chief Operating Officer
- Cloyd Mary Ann, Director
- Lathan Corinna, Director
- Li Kecheng, Director
- Scher Deborah Lafer, Director